본문 바로가기
  • Home

Improvement of Cervical Dysplasia Using Ortho-Cellular Nutrition Therapy (OCNT): A Case Report

  • CELLMED
  • Abbr : CellMed
  • 2026, 16(), pp.1~1
  • DOI : 10.5667/CellMed.spc.162
  • Publisher : Cellmed Orthocellular Medicine and Pharmaceutical Association
  • Research Area : Medicine and Pharmacy > General Medicine
  • Received : April 28, 2026
  • Accepted : April 30, 2026
  • Published : April 30, 2026

Youn Joo Ra 1

1포도나무약국

Irregular Papers

ABSTRACT

Objective: Human papillomavirus (HPV) is a common DNA virus, with more than 80% of sexually active women estimated to acquire an HPV infection before the age of 45 years. HPV plays a major role in the development of gynecological conditions, including cervical dysplasia and cervical cancer. Cervical dysplasia is characterized by abnormal changes in cervical cells and tissues due to factors such as HPV infection, smoking, and stress. It is diagnosed using cervical cytology and colposcopy and graded according to the extent of abnormal cellular involvement. Management ranges from follow-up surveillance to direct lesion removal, depending on disease grade. Case Report: This case involved a Korean woman in her 20s diagnosed with cervical dysplasia who additionally presented with severe dysmenorrhea, dizziness, and abnormal uterine bleeding. Ortho-Cellular Nutrition Therapy (OCNT) was administered, incorporating anthocyanins, omega-3 fatty acids, heme iron, vitamin B12, and folate. Approximately 3 months after initiating OCNT, the patient reported improvement in overall symptoms. Normal findings were confirmed 6 months after the initial diagnosis, and complete recovery was assessed at a 1-year follow-up examination. Conclusion: As this report involved a single patient, there are limitations in applying the same OCNT protocol universally to all patients with cervical dysplasia. Nevertheless, this case is meaningful in demonstrating that symptomatic and disease improvement can be achieved through a simple OCNT intervention.

Citation status

* References for papers published after 2024 are currently being built.